Studies demonstrate that dysregulation of HO-1 correlates with neurodegeneration, encompassing Parkinson’s and Alzheimer’s diseases, brain inflammation, and disturbances in nervous system homeostasis. This evidence concerns the gene HMOX1 and early-onset autosomal dominant Alzheimer disease.